← k3vl4r
Log inGet started →

PRCT (Procept BioRobotics Corp) Price Forecast

AI-generated price forecast for Procept BioRobotics Corp (PRCT) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of October 2026: K3vl4r's AI model currently reads PRCT as 2/2 bullish · strong across its horizons (2 of 2 timeframes pointing up), with a last price of 17.02. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

17.02

AI outlook

2/2 bullish · STRONG

Timeframes up

2 / 2

Share𝕏PostTelegram

PRCT forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour———
4-hour———
Daily~3 months out▲ Up+107.14%100%
Weekly~1.8 years out▲ Up+75.58%—

Latest PRCT news

From the market-news feed the forecasts are read against.

  • PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives $25.09 Average Target Price from Brokerages · ldr:themarketsdaily.com · Sep 23
  • PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Given Consensus Recommendation of "Hold" by Analysts · ldr:marketbeat.com · Sep 20
  • LAWSUIT NOTICE: NASDAQ: PRCT Investors who lost money with PROCEPT BioRobotics Corporation shares should contact the Shareholders Foundation · ldr:biopharmawatch.com · Sep 15

🔒

See the full PRCT forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

PRCT forecast — frequently asked

Will PRCT go up?

K3vl4r's AI model currently reads PRCT as 2/2 bullish · STRONG — 2 of 2 forecast horizons point up, so the overall read is leaning to the upside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the PRCT price prediction for 2026?

K3vl4r's model projects PRCT toward $17.14 over the next ~3 months, a +1.1% move from $16.96. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could PRCT reach?

Over its longest horizon (~~1.8 years), the model's projected target for PRCT is $18.36 (+0.8% vs $18.22). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

TNONQUREBMEAALCCOCPARQTSNDALIMNUPCCRMDSIGANNVCREPLGRCE

Will PRCT reach…?

Will PRCT reach $20.00?Will PRCT reach $25.00?Will PRCT reach $50.00?Will PRCT reach $100.00?

Or see the full PRCT price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare PRCT

PRCT vs TNONPRCT vs QUREPRCT vs BMEAPRCT vs ALCPRCT vs COCPPRCT vs ARQT

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.